Page 103 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences ABT for NDO

doi: 10.1023/a:1017995810755 18. Beeckman D, Van Lancker A, Van Hecke A, Verhaeghe S.
A systematic review and meta-analysis of incontinence-associated
15. He H, Zhang S, Tighe S, Son J, Tseng SC. Immobilized
heavy chain-hyaluronic acid polarizes lipopolysaccharide- dermatitis, incontinence, and moisture as risk factors for pressure
activated macrophages toward M2 phenotype. J Biol Chem. ulcer development. Res Nurs Health. 2014;37:204-218.
2013;288:25792-25803. doi: 10.1002/nur.21593
doi: 10.1074/jbc.M113.479584 19. Ku JH. The management of neurogenic bladder and quality
of life in spinal cord injury. BJU Int. 2006;98:739-745.
16. Zhu YT, Li F, Zhang Y, et al. HC-HA/PTX3 purified
from human amniotic membrane reverts human corneal doi: 10.1111/j.1464-410X.2006.06395.x
fibroblasts and myofibroblasts to keratocytes by activating 20. Allen KJ, Leslie SW. Autonomic dysreflexia. In: StatPearls.
BMP signaling. Invest Ophthalmol Vis Sci. 2020;61:62.
Treasure Island (FL): StatPearls Publishing; 2023.
doi: 10.1167/iovs.61.5.62
21. Linsenmeyer TA. Use of botulinum toxin in individuals with
17. Wynn TA. Cellular and molecular mechanisms of fibrosis. neurogenic detrusor overactivity: State of the art review.
J Pathol. 2008;214:199-210. J Spinal Cord Med. 2013;36:402-419.
doi: 10.1002/path.2277 doi: 10.1179/2045772313Y.0000000116

Volume 7 Issue 2 (2024) 7 doi: 10.36922/itps.2037